News
5don MSN
If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
That said, Recursion doesn't have a single therapy on the market yet. Over the past four years, the company has made little ...
Recursion Pharmaceuticals › According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (NASDAQ: RXRX) stock was shedding more than 17% of its value week-to-date as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback